Uniphar is a dynamic global healthcare company with more than 3,500 employees worldwide and active in 160 countries. We are a trusted global partner to pharma and Medtech manufacturers, working to unlock access to innovative therapies and optimise value for brands globally while improving patient access to medicines around the world.
Our Pharma division provides tailored specialist services and solutions for our clients’ changing needs throughout every stage of the product lifecycle. Our highly experienced access team deliver best-in-class access programs to the pharmaceutical and biotech industries, with a personal touch and true passion for patient outcomes. We leverage our extensive therapy area experience and local and global launch expertise to deliver medical affairs strategies tailored to your market, while our commercial team launch assets, fully commercialise in-licensed therapies and manage established products using innovative digital and in-person solutions to deliver success.